28.8 C
New York
Sunday, June 14, 2026

Tag: kidney

newssourceFORcompanyinformationcontent1marketreleases

AREVA Institute and SeaStar Medical Announce DoD Award of Prestigious Military Grant to AREVA Institute to Evaluate SeaStar Medical’s SCD Therapy to Advance Breakthrough...

$2 million in DoD funding enables the evaluation of SeaStar Medical’s SCD therapy in the setting of severe burns, inhalation injury, and sepsis 
$2 million in DoD funding enables the evaluation of SeaStar Medical’s SCD therapy in the setting of severe burns, inhalation injury, and sepsis

Hansa Biopharma to attend BIO International Convention

LUND, Sweden, June 11, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (NASDAQ Stockholm: HNSA), today announced that Hansa's CEO Renée Aguiar-Lucander will speak at the...

Anesthesia Patient Safety Foundation Hosts Capitol Hill Briefing to Urge Adoption of Continuous Blood Pressure Monitoring as Standard of Care

WASHINGTON, June 10, 2025 /PRNewswire/ -- Today, the Anesthesia Patient Safety Foundation (APSF) proudly hosted a Capitol Hill briefing, highlighting the critical need to...

BioPorto A/S Announces the Appointment of a New CEO as Part of its Succession Planning Strategy

June 10, 2025
Announcement no. 16

Global Clinical Workflow Management Software Market Projected to Reach USD USD 40,243 million by 2030., Growing at a 22.97% CAGR: MarkNtel Advisors – Leading...

NEW DELHI, June 10, 2025 /PRNewswire/ -- The Global Clinical Workflow Management Software Market size is set to experience significant growth in the coming years....

Vera Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., June 09, 2025 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA) today announced that on June 3, 2025, the Compensation Committee granted inducement awards consisting of non-qualified stock options to purchase 124,000 shares of Class A common stock and restricted stock units (RSUs) for 65,925 shares of Class A common stock to seventeen (17) new employees under the Inducement Plan. The Compensation Committee approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing Rule 5635(c)(4).

Calliditas Therapeutics Presented at the 62nd European Renal Association Congress

STOCKHOLM, June 9, 2025 /PRNewswire/ -- Calliditas Therapeutics (Calliditas), an Asahi Kasei company, announced today that new data was presented at the 62nd European...

Superior Health Quality Alliance Selected by the Centers for Medicare & Medicaid Services (CMS) as Quality Innovation Network Quality Improvement Organization (QIN-QIO), Now Serving...

Superior Health Now Supports Medicare Providers Across 14 States and Two Territories  MADISON, Wis., June 9, 2025 /PRNewswire/ -- Superior Health Quality Alliance (Superior Health) is...

Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025

LUND, Sweden, June 9, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual investor event...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsKidney

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers